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Abstract
There is increasing evidence that viral infection, expression of viral protein or the presence of viral DNA causes the host cell cycle to arrest
during G2/M. The mechanisms used by viruses to cause arrest vary widely; some involve the activation of the cellular pathways that induce arrest
in response to DNA damage, while others use completely novel means. The analysis of virus-mediated arrest has not been proven easy, and in
most cases the consequences of arrest for the virus life cycle are not well defined. However, a number of effects of arrest are being investigated and
it will be interesting to see to what extent perturbation of the G2/M transition is involved in viral infections.
Crown Copyright © 2007 Published by Elsevier Inc. All rights reserved.Keywords: G2/M arrest; HPV; HIV; Life cycle; ReplicationIntroduction
An important feature of many viral infections is subversion
of the host cell cycle. Often this is apparent as a stimulation
of S phase entry in cells that would otherwise be in G1 or
G0. However it is becoming increasingly evident that the
G1/S boundary is not the only transition that is targeted by
viruses, and that many viruses are able to induce cell cycle
arrest at G2/M. In some cases the molecular basis for G2/M
arrest is known, while for others the specific pathways
involved remain unclear. In most cases it is not yet well
understood what function this modulation of the cell cycle
may play in the virus life cycle. This review summarizes the
different mechanisms used by viruses to affect the G2/M
boundary, and aims to collate the limited knowledge that is
currently available on the consequences of arrest. By
considering the strategies that have so far been used to
study G2/M arrest mechanisms among viruses, it may be
possible to develop a general approach to establish the
significance of arrest in the life cycles of the different viruses.⁎ Corresponding author. Fax: +44 20 8906 4477.
E-mail addresses: cdavy@nimr.mrc.ac.uk (C. Davy),
jdoorba@nimr.mrc.ac.uk (J. Doorbar).
0042-6822/$ - see front matter. Crown Copyright © 2007 Published by Elsevier In
doi:10.1016/j.virol.2007.05.043The normal cell cycle and G2/M arrest
The life cycle of a dividing cell can be split into four stages: G1,
S, G2 and mitosis, with cells that are no longer cycling being said
to be quiescent or inG0. The two gap phases, G1 and G2, separate
S phase, during which the DNA is replicated, and mitosis, in
which it is divided between two new nuclei. After mitosis, the cell
itself divides and each daughter cell begins the cycle again from
G1, or exits the cell cycle into G0. Progression from one stage to
the next is controlled by the activities of kinase complexes made
up of cyclins bound to cyclin-dependent kinases (Cdk). These
complexes are in turn regulated by a multitude of pathways that
allow response to external stimuli, e.g., via mitogen-activated
protein kinase (MAPK) signaling, as well as to the internal
conditions of the cell, e.g., via the checkpoint pathways.
Control of mitotic entry
The control of the G2/M boundary during the normal cell
cycle, and in response to DNA damage or incomplete repli-
cation, is complex. Here we will focus only on those pathways
that will be encountered in the subsequent discussions of virally
induced G2/M arrest that are summarized in Fig. 1. A more
complete overview is provided by Stark and Taylor (2006).
During G2, cyclin B1 accumulates and forms a kinase
complex with Cdk1. The complex is kept inactive by inhibitoryc. All rights reserved.
Fig. 1. G2/M events targeted by viruses. The upper panels illustrate aspects of normal progression through G2/M. The lower panels show the sites where viruses and
viral proteins are observed to cause changes to events of the G2/M transition (but do not necessarily imply direct action at this place; the virus/viral protein may in fact
be acting somewhere upstream). Abbreviations: AAV—adeno-associated virus; APC—anaphase promoting complex; BDV—Borna disease virus; CAV—chicken
anemia virus; HPV—human papillomavirus; HSV1—herpes simplex virus type 1; JCV—JC polyomavirus; MAPK—mitogen-activated protein kinase; MMV—mice
minute virus; ODV—occlusion-derived virus; PP2A—protein phosphatase 2A. Reovirus in this instance refers to serotype 3.
220 Minireviewphosphorylation of Cdk1, catalyzed by nuclear Wee1. Although
the Cdk1/cyclin B1 complex can enter the nucleus in G2, due to
its fast rate of nuclear export it is predominantly cytoplasmic. In
late G2, Cdc25C activates the kinase complex by depho-
sphorylating Cdk1. Inhibition of cyclin B1 nuclear export
promotes the accumulation of the complex in the nucleus, where
it stimulates entry into mitosis. Eventually the Cdk1/cyclin B1
complex is inactivated by the anaphase-promoting complex
(APC), a ubiquitin ligase that targets cyclin B1 for degradation.
Without the activity of the APC, the cells are unable to exit
mitosis. Passage through mitosis also requires that the mitotic
spindle fibers attach to the chromosome via a complex of
proteins called the kinetochore, and pull the sister chromatids
apart. Successful G2/M transition and exit from mitosis are
regulated by a multitude of other kinases and phosphatases,including protein phosphatase 2A, PP2A, which has multiple
cell cycle targets and therefore pleiotropic effects on the cell.
In the presence of DNA damage or incomplete replication, it
is important that the cell prevents mitotic entry. The pathways
that monitor and induce G2 arrest under these conditions are
examples of “checkpoints” and result in the activation of the
ATM and ATR kinases. Both ATM and ATR phosphorylate
Chk1 and Chk2 leading to the activation of these kinases and
subsequent phosphorylation of Cdc25C. The binding of 14-3-3
to phosphorylated Cdc25C sequesters this phosphatase in the
cytoplasm, preventing it from activating the Cdk1/cyclin B1
complex. In addition to maintaining inactive Cdk1/cyclin B1
complexes, the checkpoint pathways can also prevent their
nuclear accumulation. After the initial induction of G2 arrest, the
arrest may be sustained via activation of other pathways that are
221Minireviewtypically regulated by p53. One regulator whose expression can
be controlled by p53 is the p21 protein. By binding directly to
Cdk/cyclin complexes, p21 is able to inhibit their kinase activity.
The diversity of G2/M arrest strategies used by viruses
A variety of viruses have been associated with G2/M arrest,
including DNA viruses, RNA viruses and retroviruses but the
methods by which arrest is achieved appear very diverse (see
Fig. 1). Although in many cases the mechanisms are not fully
characterized, observations have been made that implicate
particular pathways. What follows is an attempt to broadly
group the strategies used by the different viruses.
Inhibition of Cdk1/cyclin B1 kinase activity
In a number of instances, G2 arrest has been linked to an
inhibition or delay in the activation of Cdk1/cyclin B1 kinase
activity (Fournier et al., 1999; De Beeck et al., 2001; Planz et al.,
2003). This can result either from the induction of Cdk inhibitors
such as p21, for example as occurs with JC polyomavirus
agnoprotein (Darbinyan et al., 2002), or via maintenance of
Cdk1 phosphorylation (Poggioli et al., 2001; Scarano et al.,
1994), as proposed for the human papillomavirus (HPV) type 1
E4 protein (Knight et al., 2006). The mechanisms used by these
viruses to mediate arrest appear to vary widely, and are not
always fully understood, but it appears that in several cases,
components of the DNA damage checkpoint pathways may be
activated. Our current understanding of how these viruses
achieve arrest is outlined diagrammatically in Fig. 1.
Inhibition of nuclear accumulation of Cdk1/cyclin B1
complexes
In some instances, mitosis can be inhibited even in the
presence of active Cdk1/cyclin B1 complexes, provided they are
prevented from accumulating in the nucleus (see Fig. 1). The
parvovirus B19 NS1 protein mediates G2 arrest despite the
presence of active Cdk1/cyclin B1 in the cytoplasm (Morita et al.,
2001). The NS1 protein has nicking and helicase activities that
may damage cellular DNA (Momoeda et al., 1994; Poole et al.,
2006), and although the precise mechanism of arrest is unclear, it
may involve checkpoint pathways that regulate cyclin B nuclear
export. An alternative strategy is used by the E4 protein of
HPV16, which prevents the nuclear entry of the Cdk1/cyclin B
complex by sequestering the Cdk1/cyclin B kinase complex in the
cytoplasm (Davy et al., 2005). The association of HPV16 E4with
the cytokeratin network is thought to contribute to the ability of E4
to achieve this effect in vivo (Wang et al., 2004).
Inhibition of mitotic exit
In some cases of virally induced G2/M arrest, the cells are
able to enter but not exit mitosis. Again a variety of strategies
have been proposed, and are described more fully in Fig. 1.
Among these are the inhibition of the APC (Kornitzer et al.,
2001) by the chicken anemic virus (CAV) apoptin protein
(Teodoro et al., 2004), the interference with kinetochores by
herpes simplex type 1 (HSV-1), ICP0 protein (Everett et al.,
1999; Lomonte et al., 2001), and the expression of thebaculovirus EC27 protein (Autographa californica nucleopo-
lyhedrovirus), which may act as a non-degradable Cdk1/
cyclinB analog (Belyavskyi et al., 1998). The mechanism
underlying EC27-mediated arrest is however only poorly
understood (Ikeda and Kobayashi, 1999).
The HIV Vpr protein—an illustration of multiple potential
arrest mechanisms
By far the most studied viral G2 arrest is that induced by the
HIV Vpr protein. Although in the last 10 years, well over 20
papers, from a variety of laboratories have been published on
the subject, the exact mechanism(s) remains unclear. The Cdk1/
cyclin B1 complex is clearly inactive in Vpr-arrested cells (He
et al., 1995; Re et al., 1995), but more contentious are the
upstream pathways that lead to this inhibition. The mechanisms
that have been proposed to explain how Vpr expression may
contribute to G2/M arrest include (1) Vpr binding to chromatin
and/or splicing factors, which causes activation of ATR, and
leads eventually to changes in the activity of the Wee1 kinase
and/or the Cdc25 phosphatase (Lai et al., 2005; Terada and
Yasuda, 2006); and the less well characterized phenomena of (2)
direct binding to Cdc25C and inhibition of its phosphatase
activity (Goh et al., 2004); (3) alteration of the level of Wee1
protein (Yuan et al., 2004); (4) effects on PP2A (Elder et al.,
2001); (5) activation of the p21 promoter and p21-mediated
Cdk1/cyclin B inhibition (Chowdhury et al., 2003); and (6)
downregulation of expression of genes in the MAPK pathway
(Yoshizuka et al., 2005) (see Fig. 1).
It may be that the range of potential mechanisms identified
for Vpr is a unique feature of this viral protein, and that the G2
arrest proteins encoded by other viruses do not target so many
pathways. Alternatively, it may be that the proteins encoded by
other viruses do possess redundant or synergistic arrest
mechanisms, but that a greater effort that has been put into
understanding the biology of HIV.
G2/M arrest is not necessarily dependent on viral proteins
It is not only viral proteins that are able to elicit G2/M arrest;
adeno-associated virus (AAV)-induced G2 arrest can result
from the presence of the viral genome, a single-stranded DNA
molecule with terminal hairpin loops (Cotmore and Tattersall,
1994; Raj et al., 2001). It appears that these unusual DNA
structures, and similar ones found in other parvoviruses (Op De
Beeck and Caillet-Fauquet, 1997), are sufficient to activate a
DNA damage response. Whether these viruses have evolved to
exploit this natural cellular defence mechanism to their
advantage remains to be seen.
The consequences of G2/M arrest during the virus life cycle
In contrast to the extensive information available on the
mechanisms of G2/M arrest, few publications have examined its
role in the life cycles of the different viruses. One obvious effect
may be to prevent new cell production, which might be of
benefit to the virus if (for example) it disrupts the anti-viral
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infected lymphocytes. Interestingly, HIV-infected T lympho-
cytes isolated from patients are arrested in G2 which may limit
the immune response to the virus (Zimmerman et al., 2006).
However for the majority of viral infections where the target
cells are not those of the immune system, other aspects of the
G2/M arrest may be more significant.
Effect of G2/M arrest on very early virus life cycle events
Experiments with small molecule inhibitors have shown that
arrest at G2/M can benefit the early stages of the HIV life cycle by
increasing the number of integrated proviruses (Groschel and
Bushman, 2005), and it is hypothesized that Vpr-induced arrest
might act in a similar way. Significantly, the infectious HIV virion
contains sufficient Vpr to induce G2 arrest following infection,
and thus Vpr may be able to affect aspects of the virus life cycle
that occur prior to viral protein expression (Poon et al., 1998).
G2/M arrest and the cell cycle control of transcription and
translation
Using a variety of mechanisms, the expression of many
cellular proteins has been found to fluctuate during the cell cycle.
Virus-induced G2/M arrest may exploit these mechanisms of
regulating protein levels within the cell, in order to control the
expression of viral or cellular genes that are important for the
completion of the virus life cycle. A specific example of this
occurs during infection with the avian coronavirus, infectious
bronchitis virus, where the levels of viral protein expression
appear increased in G2/M (Dove et al., 2006). Although this
correlates with an increase in virus progeny, the mechanism for
the upregulated expression is not yet understood. In contrast, the
expression of HSV1 late proteins appears dependent on Cdk1
activity, although evidence for increased protein synthesis in G2
remains to be tested (Advani et al., 2000). Enhanced expression of
papillomavirus capsid proteins in the G2 phase of the cell cycle
has recently been proposed for HPV6 and BPV1 (Kong-Nan
Zhao, University of Queensland, Australia, personal communica-
tion). Mechanisms for increased protein expression may involve
transcription and/or translation, and for viruses with RNA
genomes, higher levels of transcription during G2/M might lead
to the production ofmore viral genomes.HIV has been reported to
be more transcriptionally active in G2 (Goh et al., 1998) and Vpr
may also modulate translation via Cdk1/cyclin B1-induced
changes in the activity of poly (A) polymerase (Mouland et al.,
2002). Another way in which viruses make use of different cell
cycle phases to regulate the extent of protein expression is via
internal ribosome entry site (IRES)-mediated translation. The
IRES sequences from hepatitis C and encephalomyocarditis
viruses appear to be downregulated in G2/M (Venkatesan et al.,
2003),while that ofHIVappears upregulated (Brasey et al., 2003).
Induction of a pseudo-S phase state to allow viral replication
For a number of DNA viruses, there is evidence that one
consequence of arrest is to establish a pseudo-S phase state, inwhich normal cellular DNA replication is complete, but where
the cell still remains competent for replication. Why might this
be beneficial to the virus? By maintaining an S phase environ-
ment, complete with substrates and the machinery for DNA
replication, DNA viruses will extend the time available to them
for the replication of their genomes. The continued replicative
state can lead to an increase in viral genome copy number and to
the replication of cellular DNA beyond 4n. This occurs during
infections with murine and SV40 polyomaviruses (Lehman et
al., 1994, 2000), and following expression of the HPV type 31
E2 protein (Frattini et al., 1997). Alternatively, it may be solely
viral DNA levels that increase, as is the case with Aleutian mink
disease parvovirus (ADV) infection (Oleksiewicz and Alex-
andersen, 1997).
To create a pseudo-S phase state, inhibition of the G2 tran-
sition is not sufficient on its own, and it is necessary for the
viruses to ensure that the proteins required for DNA replication
are also present. The strategies that viruses use to achieve this
vary. Baculovirus virions contain both the viral EC27 protein
and the cellular PCNA protein, which may contribute to S phase
entry following infection (Belyavskyi et al., 1998). DNA tumor
viruses express gene products that are specifically able to
stimulate cell cycle entry, as is the case with the HPV E6 and E7
proteins (Munger et al., 2004).
The HPV life cycle—an illustration of the potential significance
of pseudo-S phases
The E4 proteins (full-length proteins also called E1^E4), of
several HPV types have been shown to stimulate cell cycle
arrest in G2 (Davy et al., 2002; Knight et al., 2004; Nakahara et
al., 2002) and it has been shown in vivo that viral genome
amplification coincides with E4 expression (Doorbar et al.,
1997; Peh et al., 2002). It has also been observed in an
organotypic raft culture system that recreates the HPV18 life
cycle, that viral genome amplification occurs in cells that are in
G2 in the absence of cellular DNA replication (Louise Chow,
University of Alabama, Birmingham, USA, personal commu-
nication). Although the exact details of the life cycle and the
mechanism of E4-mediated G2 arrest appear to vary somewhat
between different papillomavirus types (see Fig. 2), knock-out
experiments have demonstrated an important role for E4 in the
amplification of viral genomes in the upper layers of infected
epithelium (Nakahara et al., 2005; Peh et al., 2004; Wilson et
al., 2005). In this instance, it is thought that E4 contributes to the
elevated level of replication by stimulating a G2 arrest
environment, which in the presence of E7 expression (and the
stimulation of replication proteins) leads to the formation of a
replication competent pseudo-S phase state. The mechanism by
which E4, which acts at the G2/M boundary, and E7, which acts
at the G1/S boundary are thought to work together during
natural infection is shown in Fig. 2.
Effect of G2/M arrest on late virus life cycle events
Late events such as virion assembly and release may also be
affected by cell cycle stage. It has been hypothesized that
Fig. 2. G2 Arrest during the human papillomavirus (HPV) life cycle. The expression patterns of key HPV proteins including E7, which drives cells into S phase, and
E4, which arrests cells in G2/M, are shown as vertical arrows adjacent to diagrammatic representations of infected epithelium. The images represent a model of the
HPV life cycle, and are based on data presented in Middleton et al. (2003) and Peh et al. (2002). Initial infection occurs in the basal cells (purple) and expression of the
viral E1 and E2 proteins facilitates replication of the viral episome. As the cells divide and leave the basal layer, they would normally become quiescent and
differentiate but following HPV infection they can re-enter the cell cycle as a result of E7 expression. As the cells are pushed towards the epithelial surface the levels of
E1, E2 and E4 expression increase, and the high levels of E4 protein cause the cells to arrest in G2. The continued expression of E7 in cells arrested in G2/M is thought
to create a pseudo-S phase state, which facilitates viral genome amplification rather than cell proliferation. Active genome amplification ceases following the
downregulation of E7, E1 and E2, and upregulation of the viral capsid proteins (L1 and L2). The timing of viral gene expression varies between HPV16 and HPV1
lesions but G2 arrest and amplification of the viral genomes occurs where the expression of E4 coincides with the expression of E7. The 1E4 protein is proteolytically
cleaved during differentiation with the N-terminally truncated 16-kDa form, in addition to the full-length 17-kDa form, appearing to play a role in causing G2 arrest.
Although proteolytic cleavage of HPV16 E4 occurs during differentiation, it is the full-length gene product that is responsible for growth arrest in G2. The HPV16 E4
protein prevents the nuclear accumulation of Cdk1/cyclin B1 that is required for mitosis by binding to the complex and tethering it to cytoplasmic keratins. This is
illustrated to the left of the figure.
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EC27 protein-induced G2/M arrest are involved in aspects of
virus particle maturation that are required for inter-insect
transmission of the occlusion-derived (ODV) form of the virus
(Braunagel et al., 1998). The spread of some viruses might also
be aided by the fact that cells arrested in mitosis tend to adhere
less well to neighboring cells than cells in other stages of the cell
cycle.
The relationship between mechanism and outcome of
virus-induced G2/M arrest
Although viruses from widely diverse evolutionary groups
may have evolved to target G2/M, and may even have
converged on similar mechanisms, there are likely to be
fundamental differences in the outcome of arrest for the
different viruses. The cell cycle requirements for optimal
replication of RNA viruses are presumably quite different from
those of DNAviruses. Among more closely related virus groups
we might expect to see greater similarities in the consequence of
arrest. The potential benefit of maintaining a replicative state for
viral DNA may explain why G2/M arrest in some form or
another has been observed in the small DNA tumor viruses,
adenovirus, HPV and polyomaviruses. Indeed all of these
viruses have well-characterized proteins that can push cells out
of G1 and into S phase; E1A (adenovirus), E7 (HPV), and large
T (polyomaviruses). It will be interesting to see whether they all
simultaneously express G2 arrest proteins during genome
amplification in order to create a pseudo-S phase state.
The differing requirements of viruses may in part explain the
diverse mechanisms used to induce G2/M arrest, and theircellular targets may reflect the need to activate other important
cellular pathways. For example, HIV requires activation of a
DNA damage response in order to efficiently integrate into the
host cell chromosome (Daniel et al., 2005). By targeting early
components of the checkpoint pathway, it may be that Vpr can
simultaneously promote G2/M arrest, which increases levels of
viral transcription, and activate the DNA repair mechanisms
that are required for integration. By contrast, HPV type 16 does
not require activation of the DNA damage response since its
DNA is maintained as an extrachromosomal episome and
therefore it can target cyclin B1 directly, which is a more
downstream component of the G2/M pathway (see Fig. 2).
Difficulties associated with the analysis of viral G2/M arrest
For most viruses it has been proven very difficult to precisely
define the mechanisms and outcomes of G2/M arrest. Such
problems are evidenced by the abundance of papers that have
examined the mechanism of Vpr-induced arrest in HIV. For
example, Vpr may target mitotic entry in at least five different
ways, and it remains unknown how many of the identified
pathways are relevant. The challenge is to identify those that are
of biological significance. To do this successfully, a number of
issues must be considered. Some of these are common to other
areas of biology, while others relate to difficulties in working
with viruses and/or the cell cycle.
The complexities of cell cycle control
The cell cycle is controlled not by a series of discrete, linear
pathways but by a complex web of interactions that as yet are
not fully understood. Viral proteins may appear therefore to be
224 Minireviewacting through a number of regulatory pathways, when in fact
their target is a common upstream event. In some cases of
course, viral proteins may indeed have multiple targets, but
there is still a need to distinguish events that lead to G2/M arrest
from changes that ensue in the arrested cell. Cause and effect
can be a particular problem in cell cycle experiments, where
changes that might be expected to cause arrest (such as
abnormal levels of Cdk/cyclin activity) may instead be the result
of arrest by other mechanisms. The use of siRNA and/or cellular
knock-outs has been proven a powerful technique for addres-
sing this problem. Unfortunately, for the analysis of many cell
cycle proteins this can be problematic, either because the results
would be too detrimental to normal cellular proliferation or
because of degeneracy among the activities of cell cycle control
proteins. Cells may also react differently to viral proteins
depending on when in the cell cycle these proteins are
expressed, and this may cloud interpretation when cells are
synchronized using drugs or other methods. The use of drugs to
modulate specific cell cycle pathways can also be problematic,
as many such drugs are known to exert pleiotropic effects on the
cell (e.g., the use of okadaic acid to inhibit PP2A).
Choice of model system
Rarely can viral G2/M arrest be studied during a natural
infection. For ease, experiments are often carried out in
transformed cell lines but as these often exhibit abnormal cell
cycle pathways, e.g., as a result of p53 deletions, the real effect
of the viral protein may be masked. Ideally a number of cell
types should be assayed, and the choice should reflect as far as
possible the natural host of the virus, because different cell types
respond differently to arrest stimuli. During our analysis of the
mechanism of HPV16 E4-induced G2 arrest we have observed
discrepancies between results obtained from Schizosaccharo-
myces pombe (a commonly used model system for cell cycle
experiments) and those from mammalian cells (C. Davy and D.
Jackson, unpublished observations).
Reliance on mutants, knock-outs or over-expression
The multifunctional nature of viral proteins makes it difficult
to attribute one activity to a particular role in the life cycle. For
example, expression of the HPV type 31 E2 protein can increase
viral copy number but it is not straightforward to say what
contribution E2-induced G2 arrest makes to this because
another function of E2 is to recruit replication proteins to the
viral ori. Such difficulties are often compounded in experi-
mental systems by the problem of over-expression, which can
facilitate non-physiological interactions as a result of alterations
in protein abundance or subcellular localization.
Experiments that use mutant viral proteins also need to be
interpreted cautiously as several binding partners and activities
may be affected, some of which may not be known. Such
experiments are useful in disproving causal relationships. For
example, the significance of the Vpr binding protein HHR23A
which was initially thought to be critical for G2 arrest was
shown to be less important after a mutant Vpr was identified
that was no longer able to bind to HHR23A, but which was still
able to induce G2 arrest (Mansky et al., 2001). The need tocarefully interpret mutant data is further emphasized by the
R80A G2 arrest mutation in Vpr. R80A does not bind to PP2A,
but neither does it activate the p21 promoter, associate with
Cdc25C, nor downregulate gene expression in the MAPK
proliferation pathway, which makes functional interpretation of
its significance particularly difficult.
Summary
The ability to induce G2/M arrest is a feature of viruses from
a range of different families. Interestingly, the arrest mechan-
isms vary widely, and do not correlate with their taxonomic
classifications. Although the outcomes of arrest are in general
less well characterized than the mechanisms, a number of
potential consequences have been identified. In some cases
these do seem to be common to virus groups, such as the
increase in viral genome copy number that is seen among some
DNA viruses, but there is still much work to be done before the
role of G2/M arrest in the life cycle of different viruses is
properly understood. The most well-established mechanisms
and outcomes are those that have been determined using a
variety of approaches, and which make use of model systems
that closely mimic natural infection. Hopefully by using such
multi-faceted approaches, the mechanism of action, and the
consequence of G2/M arrest can be established in the life cycle
of the different viruses.
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